For more than 40 years ASHP has published the most trusted resource for injectable drug information. Our new ASHP??? Injectable Drug Information now delivers the same high-quality content that you can expect from ASHP with even more of the information you need to make decisive patient care decisions. The 2023 edition of the industry's go-to guide is newly updated with the latest information, the full list of the AHFS??? Pharmacologic-Therapeutic Classification??? system, multiple new monographs, and nearly 200 new ...
Read More
For more than 40 years ASHP has published the most trusted resource for injectable drug information. Our new ASHP??? Injectable Drug Information now delivers the same high-quality content that you can expect from ASHP with even more of the information you need to make decisive patient care decisions. The 2023 edition of the industry's go-to guide is newly updated with the latest information, the full list of the AHFS??? Pharmacologic-Therapeutic Classification??? system, multiple new monographs, and nearly 200 new references for a total of over 24,000 total compatibility pairs. ASHP??? Injectable Drug InformationTM 2023 features more than 400 monographs, including: Brexanolone Cefiderocol sulfate tosylate Oritavancin Oliceridine fumarate Remdesivir Remimazolam besylate Sildenafil citrate
Read Less
Add this copy of ASHP® Injectable Drug InformationTM: A Comprehensive to cart. $495.89, new condition, Sold by booksXpress, ships from Bayonne, NJ, UNITED STATES, published 2022 by American Society of Health-System Pharmacists.
Edition:
2022, American Society of Health-System Pharmacists
